Retrospective Evaluation of Nivolumab in First-line unresectable advanced or metastatic Gastric Cancer (GC) and Gastroesophageal Junction Cancer (GEJC) : A Non-interventional Study in China (ChiCTR) - Oct 16, 2026 - P=N/A | N=260 | Completed | Sponsor: Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology; Tongji Hospital, Tongji Medical College ,Huazhong University o | Not yet recruiting ➔ Completed
Trial completion • Esophageal Cancer • Gastric Cancer • Oncology • Solid Tumor
|